Back to Search
Start Over
Supplementary Data from Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect
- Publication Year :
- 2023
- Publisher :
- American Association for Cancer Research (AACR), 2023.
-
Abstract
- Supplementary methods, data and Figures
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....650945d96b4cb4ca36cc61fe8daa399d
- Full Text :
- https://doi.org/10.1158/1535-7163.22522479